Coronavirus channel feed – Endpoints News

Coronavirus channel feed

HHS launches $500M universal vaccine platform as RFK Jr. shakes up US vaccine policy

Last week

Vaxart says it can resume next-gen Covid work, will screen participants for oral vaccine trial

Last week

Novavax responds to FDA’s trial ask, with Covid vaccine strain updates under scrutiny

Last week

FDA asks Novavax for post-marketing data of its Covid vaccine, delaying approval

3 weeks ago

Vaccine biotechs say they’ve been told to stop next-gen Covid work under a Biden-era project

3 weeks ago

Moderna stands by its Covid vaccine IP after decision axing two patents

2 months ago

Shionogi lands $375M from HHS to develop preventive drug for Covid-19

3 months ago

Moderna lowers 2025 revenue estimate, announces more cost cuts

3 months ago

Leyden Labs gets $70M to test if nasal sprays can help protect against viruses

4 months ago

BioNTech settles with NIH, UPenn in Covid vaccine disputes and will pay royalties

4 months ago

During Covid, RFK Jr. lobbied against vaccine EUAs for children. As HHS secretary, he could rescind them

5 months ago

In surprise, study suggests Covid mRNA vaccines may boost cancer immunotherapy efficacy

7 months ago

Atea's polymerase inhibitor fails in late-stage Covid-19 treatment trial

7 months ago

FDA authorizes Novavax's updated Covid booster

8 months ago

Invivyd says new Phase 3 data on Covid antibody support prophylactic use

8 months ago

Pfizer unveils direct-to-consumer push for Covid, flu and migraine treatments

8 months ago

FDA approves reformulated Covid boosters for fall season

8 months ago

Exclusive: Covid and epidemic threat biotech Aerium Therapeutics closes after emergence of variants

9 months ago

Pfizer and BioNTech say GSK's Covid patent suit is 'groundless'

9 months ago

US bankrolls a third of global Pandemic Fund. Can it get congressional support?

9 months ago

EMA reasserts differences with FDA for Covid vaccine strain selection

9 months ago

Inside BARDA's multibillion-dollar effort to fund long-shot biotechs for Covid

10 months ago

FDA asks Covid-19 vaccine makers to instead target KP.2 strain for fall season

11 months ago

Vaxart wins $453M in BARDA funding for oral Covid-19 vaccine

11 months ago

12 3 4 Next page Last page